US Blood Transfusion Diagnostics Market

ID: MRFR/LS/17162-HCR
100 Pages
Vikita Thakur
Last Updated: April 06, 2026
US Blood Transfusion Diagnostics Market Research Report: Size, Share, Trend Analysis By Product Type (Infectious Disease Testing, Blood Grouping Tests, Compatibility Testing, Nucleic Acid Testing), By Technique (Enzyme-Linked Immunosorbent Assay, Polymerase Chain Reaction, Chemiluminescent Immunoassay, Microbiological Techniques), By End Users (Hospitals, Blood Banks, Diagnostic Laboratories, Academic Institutions) and By Applications (Transfusion Medicine, Organ Transplantation, Clinical Research) - Growth Outlook & Industry Forecast 2025 To 2035
US Blood Transfusion Diagnostics Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.89%
2024 Market Size$ 2,295.16 Million
2025 Market Size$ 2,430.34 Million
2035 Market Size$ 4,308.57 Million
Key Players
Roche Diagnostics
Abbott Laboratories
Grifols
Terumo Corporation
Baxter International
Ortho Clinical Diagnostics
Trends
  • Technological Advancements
  • Regulatory Compliance
  • Increased Demand for Blood Products
Opportunities
  • Growing Awareness of Blood Safety
  • Rising Prevalence of Blood Disorders
  • Regulatory Changes and Quality Standards
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Product Type (USD Million)
      1. 4.1.1 Infectious Disease Testing
      2. 4.1.2 Blood Grouping Tests
      3. 4.1.3 Compatibility Testing
      4. 4.1.4 Nucleic Acid Testing
    2. 4.2 Chemicals and Materials, BY Technique (USD Million)
      1. 4.2.1 Enzyme-Linked Immunosorbent Assay
      2. 4.2.2 Polymerase Chain Reaction
      3. 4.2.3 Chemiluminescent Immunoassay
      4. 4.2.4 Microbiological Techniques
    3. 4.3 Chemicals and Materials, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Blood Banks
      3. 4.3.3 Diagnostic Laboratories
      4. 4.3.4 Academic Institutions
    4. 4.4 Chemicals and Materials, BY Application (USD Million)
      1. 4.4.1 Transfusion Medicine
      2. 4.4.2 Organ Transplantation
      3. 4.4.3 Clinical Research
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Roche Diagnostics (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Abbott Laboratories (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Grifols (ES)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Terumo Corporation (JP)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Baxter International (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Ortho Clinical Diagnostics (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Bio-Rad Laboratories (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Hologic (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 US MARKET ANALYSIS BY TECHNIQUE
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY APPLICATION
    6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    12. 6.12 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
    13. 6.13 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 (% SHARE)
    15. 6.15 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 TO 2035 (USD Million)
    16. 6.16 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
    17. 6.17 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
    18. 6.18 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
    19. 6.19 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY TECHNIQUE, 2025-2035 (USD Million)
      3. 7.2.3 BY END USER, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Blood Transfusion Diagnostics Market Segmentation

US Blood Transfusion Diagnostics Market By Product Type (USD Million, 2025-2035)

  • Infectious Disease Testing
  • Blood Grouping Tests
  • Compatibility Testing
  • Nucleic Acid Testing

US Blood Transfusion Diagnostics Market By Technique (USD Million, 2025-2035)

  • Enzyme-Linked Immunosorbent Assay
  • Polymerase Chain Reaction
  • Chemiluminescent Immunoassay
  • Microbiological Techniques

US Blood Transfusion Diagnostics Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Academic Institutions

US Blood Transfusion Diagnostics Market By Application (USD Million, 2025-2035)

  • Transfusion Medicine
  • Organ Transplantation
  • Clinical Research

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.